Diseases, Conditions, Syndromes

DMARDs may be underused for low back pain

(HealthDay)—Disease-modifying antirheumatic drugs (DMARDs) may be underutilized for treatment of low back pain (LBP), according to a review published online June 1 in Pain Practice.

Surgery

The opioid epidemic and its impact on orthopaedic care

The United States makes up less than five percent of the world's population but consumes 80 percent of the global opioid supply and approximately 99 percent of all hydrocodone—the most commonly prescribed opioid in the ...

Psychology & Psychiatry

Omega-3 may help depression caused by certain types of inflammation

In a study published in the journal Molecular Psychiatry, researchers found that the omega-3 fatty acid EPA (eicosapentataenoic acid) appears to boost mood in a subgroup of patients with major depressive disorder (MDD) who ...

Medical research

Researchers discover why drug for severe COPD becomes less effective

Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing ...

Diseases, Conditions, Syndromes

New drug for Crohn's disease shows early promise

(HealthDay)—An experimental drug may quickly quash symptoms of the digestive disorder Crohn's disease—at least for the short term, an early clinical trial finds.

Arthritis & Rheumatism

Guidelines provided for viscosupplementation in knee OA

(HealthDay)—For patients with knee osteoarthritis, the evidence should be considered before recommending viscosupplementation, according to a case vignette study published in the March 12 issue of the New England Journal ...

page 35 from 40